Abstract
Gut microbiota is increasingly recognized as a metabolic organ essential for human health. Compelling evidences show a variety set of links between diets and gut microbial homeostasis. Changes in gut microbial flora would probably contribute to the development of certain diseases such as diabetes, heart disease, allergy, and psychiatric diseases. In addition to the composition of gut microbiota, the metabolites derived from gut microbiota have emerged as a pivotal regulator in diseases development. Since high-fat and high-protein diets substantially affect the gut microbial ecology and human health, the current review summarizes the gut microbiota-derived metabolites such as short-chain fatty acids (SCFAs), amino acids, and their derivatives and highlights the mechanisms underlying the host responses to these bioactive substances.
Highlights
Intestine is a complex ecosystem harboring a diversity of microbial community known as the gut microbiota
Emerging data show that an aberrant gut microbiota composition is associated with several diseases, such as metabolic disorders and inflammatory bowel disorder (IBD) [5]
short-chain fatty acids (SCFAs) can modulate the progression of inflammatory diseases either by inhibiting histone acetylase (HDAC) activity, and thereby affecting gene transcription, or through the activation of metabolite-sensing G-protein coupled receptors (GPCRs) such as GPR43
Summary
Intestine is a complex ecosystem harboring a diversity of microbial community known as the gut microbiota. A growing body of research has focused on the microbially produced metabolites such as short-chain fatty acids (SCFAs), amino acids, and their derivatives cometabolized by the host [8]. Dietary fibers and proteins and peptides, which escape digestion from host enzymes in the upper gut, are metabolized by the microbiota in the cecum and colon [10].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have